Prosecution Insights
Last updated: September 17, 2026
Application No. 18/992,843

NEURAL NETWORK-BASED MEDICAL IMAGE PROCESSING APPARATUS AND METHOD

Non-Final OA §103
Filed
Jan 09, 2025
Priority
Jul 21, 2022 — RE 10-2022-0090390 +1 more
Examiner
YENTRAPATI, AVINASH
Art Unit
Tech Center
Assignee
Intromedic Co. Ltd.
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
1y 3m
Est. Remaining
70%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
517 granted / 692 resolved
+14.7% vs TC avg
Minimal -4% lift
Without
With
+-4.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
29 currently pending
Career history
708
Total Applications
across all art units

Statute-Specific Performance

§101
10.5%
-29.5% vs TC avg
§103
54.6%
+14.6% vs TC avg
§102
22.1%
-17.9% vs TC avg
§112
11.4%
-28.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 692 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1, 16 are rejected under 35 U.S.C. 103 as being unpatentable over D11 and further in view of D22. With regard to claim 16, D1 teach method of processing a medical image based on a neural network, in which a small bowel region is classified from medical images acquired by capsule endoscopy (see abstract: capsule endoscopy images, deep learning neural network), the method comprising: inputting the medical images to an organ classification algorithm (see abstract, fig. 4, 11: inputting images into deep learning neural network); and classifying the small blow region from the medical images by the organ classification algorithm (see abstract, fig. 4, 11, ¶¶ 81-82: classifying the small bowel region), the organ classification algorithm comprising: a convolutional neural network algorithm configured to distinguish the small bowel region by classifying organs contained in the medical image into a stomach, a small bowel and a colon (see abstract, fig. 4, 11, ¶¶ 81-82, 94: classifying the regions into pre-small bowel or stomach, small bowel and colon). D1 fails to explicitly teach a temporal filtering algorithm linked to the convolutional neural network algorithm and configured to reduce images misclassified by the convolutional neural network algorithm. However, D2 teach the missing feature (see D2 abstract, fig. 1: temporal convolution neural network for segmentation). One skilled in the art before the effective filing date would have found it obvious to combine the teachings to arrive at the claimed invention. In particular, D1 is related to segmentation of small bowel and colon structures from images of captured using a capsule endoscopy. Separately, D2 teaches using temporal filtering to segment images. It would have been obvious for one skilled in the art to modify the neural network of D1 with the neural network of D2 for segmenting sequence of temporal images captured by the endoscopy yielding predictable and enhanced results using temporal information. With regard to claim 1, see discussion of claim 16. D1 inherently uses a memory and processor (see fig. 3). Claims 2-19 objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Pertinent Art Saito et al.3 is related to classification of endoscopic images captured using a capsule endoscopy. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to AVINASH YENTRAPATI whose telephone number is (571)270-7982. The examiner can normally be reached on 8AM-5PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sumati Lefkowitz can be reached on (571) 272-3638. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AVINASH YENTRAPATI/Primary Examiner, Art Unit 2672 1 US Publication No. 2023/0148834. 2 Farha, Yazan Abu, and Jurgen Gall. "Ms-tcn: Multi-stage temporal convolutional network for action segmentation." Proceedings of the IEEE/CVF conference on computer vision and pattern recognition. 2019. 3 US Publication No. 2022/0020496.
Read full office action

Prosecution Timeline

Jan 09, 2025
Application Filed
Sep 10, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12737838
Lightweight Dense Residual Network for Video Super-Resolution on Mobile Devices
3y 3m to grant Granted Sep 15, 2026
Patent 12737913
INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND RECORDING MEDIUM
2y 6m to grant Granted Sep 15, 2026
Patent 12738444
HYBRID BACKGROUND EXTRACTION IN ELECTRON HOLOGRAPHY
2y 5m to grant Granted Sep 15, 2026
Patent 12738157
Method and System for the Camera-Based Determining of the Speed of a Vehicle in Traffic
2y 1m to grant Granted Sep 15, 2026
Patent 12737985
COMPUTATIONAL LOCALIZATION OF FIBRILLATION SOURCES
1y 0m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
70%
With Interview (-4.3%)
2y 11m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 692 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month